Tigulixostat Alleviates Hyperuricemic Nephropathy by Promoting M2 Macrophage Polarization.

J Inflamm Res · 2025 · PMC11705990 · PMID 39780982

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

More specifically, we observed a decreasing trend followed by stabilization in the levels of uric acid, xanthine, and adenine in the Tigulixostat group, which indicated that Tigulixostat had a stable decreasing effect on SUA.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.